Tarsier Pharma
TARXBiotech & Healthcare · NASDAQ · IPO April 21, 2026
01
Company Overview
Tarsier Pharma is filing to list on an exchange. Public information at this stage is limited to the IPO calendar entry; deeper detail typically becomes available closer to pricing via the company's S-1 / prospectus.
Tarsier Pharma is going public on an exchange on 2026-04-21.
Recent headlines
- Tarsier Pharma Ltd. (TARX) Stock Price, Quote, News & Historynasdaq.com
Tarsier Pharma Ltd. (TARX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
- Tarsier Pharma files for 5M share NYSE IPO at $8-$10/shinvesting.com
Tarsier Pharma (TARX) on Monday filed for 5,000,000 share IPO on NYSE at $8-$10 per share. Tarsier ...
- Israel-based ocular disease biotech Tarsier Pharma sets terms for ...firstwordpharma.com
According to Renaissance Capital, Israel-based ocular disease biotech Tarsier Pharma has announced terms for a $45 million IPO on Nasdaq, ...
- Tarsier Pharma sets terms for $45 million US IPO | The Pharmaletterthepharmaletter.com
Tarsier Pharma, an Israel-based Phase III biotech developing steroid-free therapies for ocular diseases, today announced terms for its ...
- TARX | Tarsier Pharma - Pre-IPO - MarketWatchmarketwatch.com
Company. Tarsier Pharma. Address. N/A. City/State ; Employees. 3. Founded ; Founded. 2016 ; File Date. 4/21/2026. File Shares ; Low Price Range. 8.00.
02
AI Analysis
Possible growth narrative
Sits adjacent to Biotech & Healthcare — themes that are currently drawing meaningful capital and attention.
Risks
Newly public companies typically face limited operating history disclosure, lock-up expirations, and broader market sentiment swings around IPOs.
Volatility
Expect elevated price volatility in the first weeks of trading as supply and demand find balance.
Market attention
Recently listed — monitoring early trading activity and analyst initiations.
Educational summary only. Not investment advice.
03
Related Themes
04
IPO Information
- IPO date
- April 21, 2026
- Exchange
- NASDAQ
- Status
- Recently Listed
- Industry
- Biotech & Healthcare
- Valuation
- $57.5M raise
- Headquarters
- —
- Attention score
- 46 / 100
- Ticker
- TARX